Adult Vaccines Market, By Vaccine (Pneumococcal, Meningococcal, Mmr, Influenza, Zoster, Shingles and

Published Date: | Report Code : HC2167816


Adult Vaccines Market, By Vaccine (Pneumococcal, Meningococcal, Mmr, Influenza, Zoster, Shingles and Others), By Vaccine Type (Monovalent and Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Conjugate Vaccines), By End User (Hospitals, Clinics and Others), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2167816

Status : Published

Adult Vaccine Market has been segmented on the basis of vaccine, vaccine type, technology, end user and region. The report analyses the key growth drivers, opportunities and challenges which influence the adult vaccines market. Recent market developments and competitive strategies such as expansion, aircraft type launch and development, partnership, merger and acquisition have been included in order to draw the competitive landscape in the adult vaccines market. The report strategically identifies and profiles the key market players and analyses their core competencies in each type and end user of the adult vaccines market.

FIGURE 1 Adult Vaccines Market – Market Scope

The adult vaccine market is estimated to be USD XX million in 2020 and is projected to reach USD XX million by 2028, at a CAGR of XX% during the forecast period. Increasing incidences of contagious alignments in adults and growing prevalence of infectious diseases is anticipated to grow the market during the forecast period. Moreover, increasing government initiatives to prevent certain diseases coupled with the growing number of awareness initiatives regarding prevention of diseases with the help of vaccine will also drive the growth of the market.

A vaccine is a biological preparation which contains an agent that resembles a disease-causing microorganism and is made from attenuated microorganisms. Adult vaccine is most beneficial and cost-effective measure to prevent from potentially fatal diseases. This provides active immunity against specific harmful and disease-causing factor by stimulating the immune system to attack the agent and to prevent from serious and fatal diseases.

FIGURE 2 Adult Vaccines MARKET: by Vaccine, 2020 & 2028

Adult vaccine market has been segmented on the basis of vaccine, vaccine type, technology, end user and region.

Based on vaccine, market has been divided into, pneumococcal, meningococcal, MMR, influenza, zoster, shingles, and others. Among these pneumococcal vaccines is anticipated to hold maximum market share in 2019. According to CDC in 2018, adult needs vaccine every year for influenza owing to increase in respiratory infection, asthma, sinus problems, and other illness, thereby contributing to the market growth in forecast period.

FIGURE 3 Adult Vaccines MARKET: by Vaccine Type, 2020 & 2028

Based on vaccine type, market has been divided into monovalent and multivalent. Among these, monovalent segment projected a higher growth rate during the forecast period. The monovalent type of vaccines contains a single strain of a single antigen and are more successful in conferring immunity. Thus, monovalent vaccines are being administered mostly as compared to multivalent vaccines and contributing to the market growth.

Figure 4 Adult Vaccines MARKET: by Technology, 2020 & 2028

Based on technology, market has been divided into live attenuated vaccines, inactivated viral/bacterial vaccines, toxoid vaccines, recombinant vaccines and conjugate vaccines. Among these live attenuated vaccines technology is anticipated to hold maximum market share. Live attenuated vaccines are derived by incorporation of a pathogen’s antigenic peptides into a harmless carrier virus or bacteria. These are excellent simulation for the immune system in human body.

FIGURE 5 Adult Vaccines MARKET: by End User, 2020 & 2028

Based on end user, market has been divided into Hospitals, clinics, and others. Among these hospitals segment projected a higher growth rate during the forecast period. Due to rapid increase in development of healthcare infrastructure by many countries, development of hospitals, and government spending on facilities offered by various hospitals is expected to propel the growth of this segment. Additionally, diagnosis and treatment is available under one roof and minimizes the troubles for most of the individuals of visiting varied healthcare settings.

FIGURE 6 Adult Vaccines market: by region, 2017-2028

By region, the market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America region is projected to register a higher share during the forecast period due to presence of key players operating in the market along with an established infrastructure and government spending. This region is dominated by the U.S. with a substantial market share. U.S. have favorable Medicare coverage for adult vaccination and also have a massive presence of contagious ailments among adults that favoring growth of the adult vaccines market in this region. However, Asia Pacific region is expected to have significant market growth in coming years, due to growing awareness about preventable diseases, and many market players are constructing their manufacturing and research facilities in this region.

Further, owing to the ongoing COVID-19 pandemic, people in all over countries are taking precautions to prevent transmission. According to UNICEF, an estimated 2.43 billion doses of vaccines is expected to reach around 100 countries to vaccinate approximately 45% of the world’s children aged under five. Vaccines were supplied in support of country programmers, in addition to outbreak and humanitarian response activities will positively impact the adult vaccine market.

The competitive scenario highlights the performance of major companies operating in this market. This includes detailed profiling of major companies and their competitive benchmarking. Product profiling provides key information including products/solutions offered, key developments, company performances, and strategies adopted in the recent years. Major companies profiled in the market include Sanofi Pasteur, Pfizer, Inc., Merck & Co, GlaxoSmithKline, Novartis, Protein Sciences, CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, AstraZeneca Plc., Bharat Biotech, Donavan Technologies Corporation, ImmunoBiology Ltd, Serum Institute of India. These companies have adopted product development, expansion, and merger strategies to consolidate market position amongst intense competition.

Market Segments

  • By Vaccine
    • Pneumococcal
    • Meningococcal
    • Mmr
    • Influenza
    • Zoster
    • Shingles
    • Others
  • By Vaccine Type
    • Monovalent
    • Multivalent
  • By Technology
    • Live Attenuated Vaccines
    • Inactivated Viral/Bacterial Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • Conjugate Vaccines
  • By End User
    • Hospitals
    • Clinics
    • Others

By Region:

  • North America Adult Vaccine Market
    • By Country (US, Canada, Mexico)
    • By Offerings
    • By Technology
    • By Application
  • Europe Adult Vaccine Market
    • By Country (Germany, Russia, UK, France, Italy, Spain, France, The Netherlands. Rest Of Europe)
    • By Offerings
    • By Technology
    • By Application
  • Asia Pacific Adult Vaccine Market
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Offerings
    • By Technology
    • By Application
  • Middle East & Africa Adult Vaccine Market
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
    • By Offerings
    • By Technology
    • By Application
  • South America Adult Vaccine Market
    • By Country (Brazil, Argentina, Colombia, Rest of South America)
    • By Offerings
    • By Technology
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the adult vaccine market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy